End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,55,930 CLP | 0.00% | 0.00% | +14.33% |
Sales 2024 * | 88.37B 79,775B 7,369B | Sales 2025 * | 90.78B 81,951B 7,570B | Capitalization | 367B 3,31,688B 30,641B |
---|---|---|---|---|---|
Net income 2024 * | 22.04B 19,895B 1,838B | Net income 2025 * | 23.09B 20,846B 1,926B | EV / Sales 2024 * | 4.08 x |
Net cash position 2024 * | 7B 6,316B 583B | Net cash position 2025 * | 21.07B 19,025B 1,757B | EV / Sales 2025 * | 3.82 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
16
x | Employees | 1,31,900 |
Yield 2024 * |
3.16% | Yield 2025 * |
3.3% | Free-Float | 77.08% |
Latest transcript on Johnson & Johnson
3 months | +6.66% | ||
6 months | +14.33% | ||
Current year | +14.33% |
Managers | Title | Age | Since |
---|---|---|---|
Joaquin Duato
CEO | Chief Executive Officer | 61 | 01/89/01 |
Joseph Wolk
DFI | Director of Finance/CFO | 57 | 01/98/01 |
James Swanson
CTO | Chief Tech/Sci/R&D Officer | 58 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marillyn Hewson
BRD | Director/Board Member | 70 | 25/19/25 |
D. Davis
BRD | Director/Board Member | 72 | 19/14/19 |
Anne Mulcahy
BRD | Director/Board Member | 70 | 22/09/22 |
Date | Price | Change |
---|---|---|
14/24/14 | 1,55,930 | 0.00% |
13/24/13 | 1,55,930 | 0.00% |
10/24/10 | 1,55,930 | 0.00% |
09/24/09 | 1,55,930 | 0.00% |
08/24/08 | 1,55,930 | 0.00% |
End-of-day quote Santiago S.E., May 14, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B | |
+0.89% | 124B |
- Stock Market
- Equities
- JNJ Stock
- JNJCL Stock